Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Christopher Stuart Casley has worked on the following 49 EPO patent applications which have been published in the last five years:

EP11730124

COMPOSITIONS AND METHODS COMPRISING SUBTILISIN VARIANTS

IPC classification:
C11D 3/386, C11D 3/39, C12N 9/54
Applicant:
The Procter & Gamble Company
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11728365

PEPTIDE-CARRYING NANOPARTICLES

IPC classification:
A61K 47/48, A61P 3/10
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11818451

ANTI-MICROBIAL COMPOSITIONS

IPC classification:
A01N 43/04, A01N 43/08, A01N 43/16, A61K 31/7042
Applicant:
Biotelliga Holdings Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP10836262

FUNGICIDAL COMPOUNDS AND METHODS OF THEIR USE

IPC classification:
A61K 36/06, A61P 31/10, C07D 493/08, C12P 17/06, C12P 17/08, C12P 17/18, C12R 1/645
Applicant:
Auckland Uniservices Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12711727

COLOR MODIFICATION OF SIZED FABRIC

IPC classification:
D06P 5/13, D06P 5/15
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722991

COMPOSITIONS AND METHODS COMPRISING SERINE PROTEASE VARIANTS

IPC classification:
C12N 9/54, C12N 15/57
Applicant:
The Procter & Gamble Company
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12796229

COMBINATION PEPTIDE-NANOPARTICLES AND DELIVERY SYSTEMS INCORPORATING SAME

IPC classification:
A61K 9/14
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12728233

DISCRIMINATION OF BLOOD TYPE VARIANTS

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12826807

INSECTICIDAL LIPID AGENTS ISOLATED FROM ENTOMOPATHOGENIC FUNGI AND USES THEREOF

IPC classification:
A01H 15/00, A01N 37/44, A01N 63/04, C07C 227/40, C07C 229/22, C12N 1/14
Applicant:
Biotelliga Holdings Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756725

NANOPARTICLE-PEPTIDE COMPOSITIONS

IPC classification:
A61K 47/48, A61P 31/00, A61P 35/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12768753

NANOPARTICLE TUMOUR VACCINES

IPC classification:
A61K 47/48, A61P 35/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14167563

In vivo incorporation of alkynyl amino acids into proteins in eubacteria

IPC classification:
A61K 47/48, C12N 9/10, C12N 9/22, C12N 15/12, C12N 15/54, C12P 21/02
Applicant:
The Scripps Research Institute
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13167128

Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13167127

Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13167130

Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10796403

HYPOXIA TUMOUR MARKERS

IPC classification:
C12Q 1/68
Applicant:
Cancer Research Technology Ltd
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12799484

ENZYME COCKTAILS PREPARED FROM MIXED CULTURES

IPC classification:
C12P 7/06, C12P 7/08, C12P 7/10, C12P 39/00
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14167479

In vivo incorporation of unnatural amino acids

IPC classification:
C07K 14/00, C12N 9/00, C12N 15/67, C12P 13/00, C12P 13/04, C12P 13/22, C12P 19/26, C12P 21/00, C12P 21/02
Applicant:
The Scripps Research Institute
Applicant:
The Regents of the University of California
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14177958

Glucoamylase variants with altered properties

IPC classification:
C12N 1/15, C12N 9/34, C12N 15/56, C12N 15/80, C12P 7/06, C12P 19/14
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14171211

Unnatural reactive amino acid genetic code additions

IPC classification:
A61K 38/17, C12N 5/00, C12N 9/00, C12N 15/67, C12N 15/85, G01N 33/53
Applicant:
The Scripps Research Institute
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13711608

TRANSGENIC ANIMAL MODEL OF MOOD DISORDERS

IPC classification:
A01K 67/027, C07K 14/475, C12N 15/85, G01N 33/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14189403

Production of thermolysin and variants thereof, and use in liquid detergents

IPC classification:
C11D 3/386, C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14194373

In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastoris

IPC classification:
C07K 16/00, C12N 1/19, C12N 15/81, C12P 21/02
Applicant:
The Scripps Research Institute
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13792210

COMPOSITIONS AND METHODS COMPRISING THERMOLYSIN PROTEASE VARIANTS

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13165441

Alpha-glucanase and oral care composition containing the same

IPC classification:
A61K 8/66, A61Q 11/00, A61Q 11/02, C12N 9/14, C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14705554

PERMEATION ENHANCED ACTIVE-CARRYING NANOPARTICLES

IPC classification:
A61K 9/14, A61K 9/51, A61K 47/48, B82Y 5/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14708315

NANOPARTICLE DELIVERY COMPOSITIONS

IPC classification:
A61K 9/00, A61K 9/51, A61K 47/48, A61K 49/18, A61P 25/00, B82Y 5/00
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14705555

NANOPARTICLE PEPTIDE COMPOSITIONS

IPC classification:
A61K 47/48, A61P 3/08
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14705556

NANOPARTICLE PEPTIDE COMPOSITIONS

IPC classification:
A61K 47/48, A61P 19/08
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14703082

DISCRIMINATION OF BLOOD TYPE VARIANTS

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14702243

GENETIC MARKERS FOR OSTEOARTHRITIS

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Agent:
SugraƱes Patentes y Marcas
Status:
EXAMINATION IN PROGRESS
EP14779926

THERAPEUTIC COMPOSITIONS COMPRISING EXTRACTS OF PROPOLIS AND USES THEREOF

IPC classification:
A61K 31/12, A61K 31/216, A61K 31/235, A61K 31/353, A61P 35/00
Applicant:
Manuka Health New Zealand Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14779790

THERAPEUTIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 35/64, A61K 47/40, A61P 1/00, A61P 35/00
Applicant:
Manuka Health New Zealand Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14807782

METHODS AND USES OF SLIT FOR TREATING FIBROSIS

IPC classification:
A61K 38/17, A61P 13/12, A61P 19/04
Applicant:
The Hospital For Sick Children
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12184900

Dental light using LEDs

IPC classification:
F21V 5/00, F21V 11/08, F21V 15/01, F21V 21/26, F21V 29/00, F21W 131/202, F21Y 115/10, F21Y 105/10
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13176407

Perhydrolase

IPC classification:
C11D 3/386, C12N 9/16, C12N 9/50, C12N 9/52
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13165442

Alpha-glucanase and oral care composition containing the same

IPC classification:
A61K 8/66, A61Q 11/00, A61Q 11/02, C12N 9/14, C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11726032

NANOPARTICLE FILM DELIVERY SYSTEMS

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/70, A61K 38/28, A61K 47/48
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15727759

ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 38/16
Applicant:
University of Oregon
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16195863

DENTAL LIGHT USING LEDS

IPC classification:
F21V 21/26, F21V 21/30, F21W 131/202, F21Y 115/10, F21Y 105/10
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15822404

PROPOLIS AND EXTRACTS THEREOF FOR THE TREATMENT OF SKIN CANCERS AND IMPROVEMENT OF SKIN HEALTH

IPC classification:
A61K 31/216, A61K 31/353, A61K 35/644, A61K 47/40, A61P 35/00
Applicant:
Manuka Health New Zealand Limited
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15741290

A METHOD FOR DETECTING A GENETIC VARIANT

IPC classification:
C12Q 1/68, G06F 19/18
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15750052

CONSENSUS-BASED ALLELE DETECTION

IPC classification:
C12Q 1/68
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15775552

PROTEINS INCREASING PANCREATIC BETA CELL NUMBER AND METHODS OF USE

IPC classification:
A61K 38/00, C07K 14/195, C12N 5/071
Applicant:
University of Oregon
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15790736

SERINE PROTEASES OF BACILLUS SPECIES

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15791844

SERINE PROTEASES

IPC classification:
C07K 14/47
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15790777

SERINE PROTEASES

IPC classification:
C11D 3/386, C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15794695

SERINE PROTEASES

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15794158

SUSTAINED RELEASE ENCAPSULATED NANOPARTICLES

IPC classification:
A61K 9/00, A61K 9/16, A61K 9/51, A61K 47/34, A61K 47/50
Agent:
Christopher Stuart Casley, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature